Improving Sleep Quality During Chemotherapy

Evidence-Based Sleep Interventions

The American Society of Clinical Oncology recommends Cognitive Behavioral Therapy for insomnia (CBT-I) as the most effective intervention for improving sleep quality in cancer patients undergoing chemotherapy, showing significant improvements in sleep efficiency, sleep onset latency, and overall sleep quality 1, 2, 3
CBT-I components have shown significant improvements in overall insomnia severity, sleep efficiency, sleep onset latency, and restorative sleep in cancer patients 1
Internet-delivered CBT programs are effective alternatives, with significant improvements in self-reported insomnia severity and sleep quality 2
Sleep efficiency can increase from 69% to 84% with CBT interventions, with improvements maintained at 12-month follow-up 4

Home-based walking/exercise programs significantly improve subjective sleep quality in cancer patients undergoing treatment 5
Exercise interventions show significantly shorter actual wake time and less movement during sleep 6
Tibetan yoga has demonstrated significantly lower sleep disturbance scores compared to control groups, with improvements in sleep quality, latency, duration, and reduced sleep medication use 6

The National Comprehensive Cancer Network recommends maintaining a regular sleep schedule, avoiding daytime napping, limiting caffeine, alcohol, and high-sugar foods before bedtime, creating a sleep environment that is dark, quiet, and comfortable, and engaging in stress-reducing activities before bedtime 7

Depression is an independent predictor of fatigue and poor sleep, according to the American College of Physicians 8
Pain, nausea, and other treatment-related symptoms can disrupt sleep, and should be evaluated and managed 5
Nutritional deficiencies and electrolyte imbalances can contribute to fatigue and sleep disturbances, and should be evaluated and treated 7
Anemia should be assessed and treated as it can exacerbate fatigue and sleep problems 8

When considering pharmacotherapy, it should be considered an adjunctive therapy to cognitive and behavioral interventions, with short-term use preferred due to potential for dependence, and dosage kept to the minimum effective amount 5, 6

Sleep disturbances are prevalent in 30-75% of cancer patients but often neglected in oncology care, according to the National Comprehensive Cancer Network 7

The American Society of Clinical Oncology recommends screening all patients undergoing chemotherapy for sleep disturbances using validated tools like the Pittsburgh Sleep Quality Index or Insomnia Severity Index 1
CBT-I should be implemented as first-line treatment, which can be delivered in various formats (individual, group, internet-based) 2, 3
Daily exercise should be incorporated when possible, tailored to the patient's condition and energy level 6
Underlying physical symptoms that may disrupt sleep should be evaluated and treated 5
Pharmacotherapy should be considered only as an adjunct to behavioral interventions and for short-term use 6